Skip to main content

Profile hero

Profile details

About Philip Li

Philip Li is a partner based in our Hong Kong office. Educated, qualified and having substantial practice experience in both China and the UK, Philip is equally comfortable with both legal systems and can understand and bridge the differences between the two across a wide range of corporate transactions.

Philip's practice focuses on three key areas: representing Chinese investors on their outbound investments; representing global financial investors on their investments in Asia, particularly China; and advising on matters involving Hong Kong-listed companies. He has extensive experience in advising clients on cross-border M&A, joint venture and private equity transactions in both the European market and in Asia.

Prior to relocating to Hong Kong, Philip spent 6 years in London acting for some of the firm’s most important private equity clients on their M&A transactions in Europe. Before his time in London, Philip was based in Shanghai.

Philip is a native Mandarin speaker and speaks fluent  English and Shanghainese.

Recent work

Recent work involving global financial investors:

  • Advised Warburg Pincus on its investments in Gaush Meditech, InSilico Medicine, Hygeia Medical
    Service Group and Car Inc and on its exit from Hygeia and Car Inc.
  • Advised Permira on its acquisition of Grobest and investment in Full Truck Alliance.
  • Advised Temasek, GIC, Mubadala, QIA, CPPIB and Khazanah Nasional Berhad on various direct
    investment and co investment deals in China. Investee companies include Mojia Biotech, JD Health, Neusoft Medical, Langdi, Ocumension, Curon Bio, Adicon, Zuoyebang, J&T Express, Tianyan Cha, Xingsheng Selected, Leqee, Klook, Mafengwo, Ziroom, Fourth Paradigm, Tongdun, DuXiaoMan and Vanke Property Management.

Recent work involving Chinese investors on their outbound investment:

  • Advised China Telecommunications on its bid for the Philippines’ third major telecommunications player license.
  • Advised Fosun on its acquisition of Sergio Rossi, restructuring of Tom Tailor and bid for Gemfields.
  • Advised China Cinda on its HK$68 billion acquisition of Nanyang Commercial Bank from Bank of China HK.

Recent work involving Hong-Kong listed companies:

  • Advised China Shanshui Cement on its debt restructuring and restoration of public float and resumption of trading on Hong Kong Stock Exchange after 3 years’ trading suspension.
  • Advised NVC Lighting on its disposal of China ligthing business to KKR.
  • Advised CITIC on the US$4.8bn sale of its residential property assets in China to China Overseas in exchange for 10 per cent of the entire issued share capital of China Overseas and certain assets owned by China Overseas.



  • Fudan University, LLB (Law)
  • New York University School of Law, LLM (Law)

Professional qualifications

  • Admitted to practise in New York (2006), England and Wales (2009) and Hong Kong (2015)
  • Chinese national bar exam (2006)